It was announced today that a temporary network of bilateral liquidity swap lines between six central banks will be made into a standing arrangement "until further notice".
I came across an interesting post with the chart below setting out one view of the primary times the three browsing platforms are used. The point seems to be that:
Risk.net conducted a poll of clearing members, a big majority of whom think CCP membership will become uneconomical under newest proposed risk-based and leverage ratio capitalization of CCP related portfolios.
Four calendar weeks are in the books. A common trend is emerging.
Moscow Exchange opened its new Standardised OTC Derivatives Market on 28th October.
I am sure you can all agree that these past few years have been a constant challenge for all, as balances and boundaries are constantly redefined, the world is trying to find its new equilibrium and all of us strive to find our way into the futur
My post a while back iOS 7 on the iPad | Don’t Go There (Yet) warne
Collateral Optimization: Beyond Cheapest to Deliver and the Big Red Button
TEDxWallStreet is radically different from a typical commercial, finance-related event.
ESMA rules deem that once one CCP is authorized to clear a given product, non-exempt participants have to clear every trade executed after that date - even if the clearing mandate for new trades is not live yet.
4sight and Intedelta would like to invite you to a webinar on how financial firms can optimize trading decisions based on:
The process for reviewing an EMIR re-authorisation application involves:
The Top Stories in Collateral Management this week:
CACEIS Launches Buy-Side Collateral Tool
In the majority of my previous articles on what we can see in SDRs, I have focused on Interest Rate Swaps and in particular Cleared Interest Rate Swaps.
The CFTC updated their list of provisionally registered Swap Dealers (SDs) on
Whilst much of the attention has been on CCPs, in the background new services are emerging to respond to the coming increase in cost and margin for un-cleared OTC business.